Budiawan, H., Salavati, A., Kulkarni, H. R., & Baum, R. P. (2013). Peptide receptor radionuclide therapy of treatment-refractory metastatic thyroid cancer using (90)Yttrium and (177)Lutetium labeled somatostatin analogs: Toxicity, response and survival analysis. e-Century Publishing Corporation.
Παραπομπή Chicago StyleBudiawan, Hendra, Ali Salavati, Harshad R. Kulkarni, και Richard P. Baum. Peptide Receptor Radionuclide Therapy of Treatment-refractory Metastatic Thyroid Cancer Using (90)Yttrium and (177)Lutetium Labeled Somatostatin Analogs: Toxicity, Response and Survival Analysis. e-Century Publishing Corporation, 2013.
Παραπομπή MLABudiawan, Hendra, Ali Salavati, Harshad R. Kulkarni, και Richard P. Baum. Peptide Receptor Radionuclide Therapy of Treatment-refractory Metastatic Thyroid Cancer Using (90)Yttrium and (177)Lutetium Labeled Somatostatin Analogs: Toxicity, Response and Survival Analysis. e-Century Publishing Corporation, 2013.